Securities Class Action

No Litigation found for Aspire Biopharma Holdings, Inc.

Material Events

Critical Governance & Disclosure

14

Board, Voting & Shareholder Rights

13

Capital Structure & Financial Risk

6

Disclosure & Communications

26

SEC Filings

PRE 14A

Other preliminary proxy statements

2026-11-20

View PRE 14A Other preliminary proxy statements on SEC.gov
8-K

Current report

2026-09-29

View 8-K Current report on SEC.gov
8-K

Current report

2026-09-09

View 8-K Current report on SEC.gov
8-K

Current report

2026-09-08

View 8-K Current report on SEC.gov
8-K

Current report

2026-08-19

View 8-K Current report on SEC.gov

Insider Transaction

No Insider Transactions found for Aspire Biopharma Holdings, Inc.